S Fukuda, LM Pelus - Molecular cancer therapeutics, 2006 - AACR
Survivin, an inhibitor of apoptosis protein, is highly expressed in most cancers and associated with chemotherapy resistance, increased tumor recurrence, and shorter patient …
DX Wang, YX Wang, J Wang, JY Ma, B Liu… - Chemical …, 2022 - pubs.rsc.org
Besides gene-editing, the CRISPR/Cas12a system has also been widely used in in vitro biosensing, but its applications in live-cell biosensing are rare. One reason is lacking …
B Nachmias, Y Ashhab, D Ben-Yehuda - Seminars in cancer biology, 2004 - Elsevier
Apoptosis is a crucial biological process that prevents uncontrolled cell proliferation and eliminates harmful cells. Resistance to apoptotic stimuli is a hallmark feature of various …
F Li, J Yang, N Ramnath, MM Javle… - International journal of …, 2005 - Wiley Online Library
Growing evidence suggests that survivin expression in cancer cell nuclei may represent an important prognostic marker to predict disease outcome for cancer patients. Current reports …
Squamous cell carcinoma (SCC) is the most common cancer worldwide. The treatment of locally advanced disease generally requires various combinations of radiotherapy, surgery …
Plasma membrane proteins that are exposed on the cell surface have important biological functions, such as signaling into and out of the cells, ion transport, and cell-cell and cell …
M Shanker, D Willcutts, JA Roth… - Lung Cancer: Targets …, 2010 - Taylor & Francis
Resistance to chemotherapy drugs is a major problem in cancer treatment. Scientific advances made in the last two decades have resulted in the identification of genes and …
SK Huang, ES White, SH Wettlaufer, H Grifka… - The FASEB …, 2009 - ncbi.nlm.nih.gov
Although the lipid mediator prostaglandin E 2 (PGE 2) exerts antifibrotic effects by inhibiting multiple fibroblast functions, its ability to regulate fibroblast survival is unknown. Here, we …
HA Elbaz, TA Stueckle, W Tse, Y Rojanasakul… - … hematology & oncology, 2012 - Springer
A growing body of evidence indicates that digitoxin cardiac glycoside is a promising anticancer agent when used at therapeutic concentrations. Digitoxin has a prolonged half …